Delivery of diagnostic agents for magnetic resonance imaging.
about
Fabrication and Characterization of Gd-DTPA-Loaded Chitosan-Poly(Acrylic Acid) Nanoparticles for Magnetic Resonance Imaging.Improved specific loss power on cancer cells by hyperthermia and MRI contrast of hydrophilic Fex Co1-x Fe2 O4 nanoensembles.PEG-functionalized magnetic nanoparticles for drug delivery and magnetic resonance imaging applications.Biocompatible Nanocomplexes for Molecular Targeted MRI Contrast Agent.Carbon-coated iron oxide nanoparticles as contrast agents in magnetic resonance imaging.Quantitative assessment of macromolecular concentration during direct infusion into an agarose hydrogel phantom using contrast-enhanced MRIMagnetic Nanoparticles: Material Engineering and Emerging Applications in Lithography and Biomedicine.Magnetic nanoparticles and their applications in medicine.Magnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imaging.Molecular imaging of alpha v beta3 integrin expression in atherosclerotic plaques with a mimetic of RGD peptide grafted to Gd-DTPA.Biomedical Nanomagnetics: A Spin Through Possibilities in Imaging, Diagnostics, and TherapyThe Behaviors of Ferro-Magnetic Nano-Particles In and Around Blood Vessels under Applied Magnetic Fields.Brain Tumor Diagnostics and Therapeutics with Superparamagnetic Ferrite Nanoparticles.T1-Enhanced MRI-visible nanoclusters for imaging-guided drug delivery.Shape-dependent cellular behaviors and relaxivity of iron oxide-based T1 MRI contrast agents.A mixture theory model of fluid and solute transport in the microvasculature of normal and malignant tissues. I. Theory.Manganese-porphyrin-enhanced MRI for the detection of cancer cells: A quantitative in vitro investigation with multiple clinical subtypes of breast cancer.Upconverting nanoparticles for pre-clinical diffuse optical imaging, microscopy and sensing: Current trends and future challengesMicrofluidic synthesis of ultra-small magnetic nanohybrids for enhanced magnetic resonance imagingThermosensitivity profile of malignant glioma U87-MG cells and human endothelial cells following γ-Fe2O3 NPs internalization and magnetic field applicationBiomedical Applications of Magnetic NanoparticlesSynthesis and characterisation of iron substituted apatite
P2860
Q30924405-3756EF07-0BAF-403E-9727-DF9070DD48FCQ31132566-CFFEE0E5-074D-4040-BC84-70F696564AB5Q33693590-9F326130-5726-4844-90A9-2948327F95CBQ33948973-F213353C-7350-4077-BEB8-B1F76CE28E62Q34119640-6B1C6241-3B85-448A-83EB-12EE370CD3B8Q35118238-8067FDF9-4339-48AD-8880-8B63A672EA8FQ36283461-2675C11D-55B2-452E-9732-63F73538D3C8Q36917874-40F59DF7-70FA-4ADF-A3BD-4FAB8942B48DQ36995530-3BBEF860-63D1-4E35-98F5-0F4100A76552Q38478306-DE8A55D6-C5A0-487B-B7D8-6E0309F91E0AQ39829640-E9AAC318-D74B-48D9-9448-D540CF61B2B8Q41946851-49A9CFB2-DFD9-4B78-BB41-340D8F54D56AQ47699015-4A985BEF-383F-4016-947F-CB8BB3476821Q47821106-31345356-C9D1-495B-9C1B-FCB7BD780736Q48513969-40CC0B8E-27E5-41C1-AE68-3DBC678710CDQ51376358-D199DD7F-98F5-48CC-B058-3DA757F426BCQ55233079-AD46B448-C52E-4AF6-A066-A98F0279CA32Q57343374-58468212-CC16-42B6-AEE4-D10FF50CDA8BQ57352096-C47A992E-6BA2-4A17-B7D7-756A6274DF59Q57559243-F415AB32-F209-4935-BE31-5628447227BFQ57967798-DCD870C1-6E71-40DE-A419-24745192A5B4Q58296083-372801C4-D809-4861-ACC0-49B9FB375A83
P2860
Delivery of diagnostic agents for magnetic resonance imaging.
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Delivery of diagnostic agents for magnetic resonance imaging.
@ast
Delivery of diagnostic agents for magnetic resonance imaging.
@en
type
label
Delivery of diagnostic agents for magnetic resonance imaging.
@ast
Delivery of diagnostic agents for magnetic resonance imaging.
@en
prefLabel
Delivery of diagnostic agents for magnetic resonance imaging.
@ast
Delivery of diagnostic agents for magnetic resonance imaging.
@en
P1476
Delivery of diagnostic agents for magnetic resonance imaging.
@en
P2093
P304
P356
10.1016/S0169-409X(98)00103-3
P407
P577
1999-04-01T00:00:00Z